• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Advocacy group Consumers Union got it wrong on med-tech, report says | MassDevice.com On Call

Advocacy group Consumers Union got it wrong on med-tech, report says | MassDevice.com On Call

April 6, 2012 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — Consumer groups are a frequent presence in discussions of medical device regulation, but one relative newcomer may have lost some points in its representation of how the industry operates in its regulatory environment.

Consumers Union, an advocacy arm of Consumer Reports, launched a charge for more stringent FDA oversight of the industry just over a year ago with its Safe Patient Project.

The group has been involved in recent regulatory discussions involving FDA user fees for the medical device industry and clearance status for Aptus Endosystems’ HeliFX endostapling system, but an analysis the group published last week received a stark review from MDDI Online.

In its report, Consumers Union portrayed medical devices as entirely lacking in safety testing, disregarding any studies that weren’t conducted in humans and saying that "for most implants and other high-risk devices brought to market, manufacturers do nothing more than file some paperwork and pay the FDA a user fee of roughly $4,000 to start selling a product that can rack up many millions of dollars in revenue," MDDI reported.

Biomet details the DePuy trauma bid

Biomet Inc. hashed out the details of its $280 million cash offer for Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopedics‘ global trauma business in regulatory documents filed this week.

Warsaw, Ind.-based Biomet hopes to expand its sports, extremities and trauma division with the acquisition, which will see DePuy’s trauma employees folded into the Biomet team in a deal that comes amid J&J’s attempted $21.3 billion buyout of Synthes.

The iPhone ECG is a rising star

The iPhone ECG proved to be a risking star, releasing study data at the American College of Cardiology conference last week touting the mobile application’s potential for uncovering otherwise undiagnosed cardiac anomalies, the Atlantic reported.

Noted physicist Stephen Hawking tests mind-controlled communication tech

Noted physicist Stephen Hawking, almost entirely paralyzed by amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, saw promise in the iBrain device, a high-tech headband that hopes to help people communicate through thoughts alone, the New York Times reported.

Handheld plasma flashlight kills dangerous pathogens on the skin

A team of scientists developed a handheld plasma-producing flashlight that may be able to instantly kill bacteria on the skin in emergency situations, such as natural disaster sites, ambulance emergency calls or military combat operations, according to a press release.

Filed Under: Mergers & Acquisitions, Neurological, News Well, Wall Street Beat Tagged With: Biomet, Consumers Union, depuysynthes, Johnson and Johnson, On Call

More recent news

  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year
  • Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford
  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy